US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

NKGen Biotech Inc.

0.0600

0.0000

Volume:1.00K

Turnover:60.06

Market Cap:7.84M

PE:-0.05

High:0.0600

Open:0.0600

Low:0.0600

Close:0.0600

52wk High:0.9100

52wk Low:0.0002

Shares:130.60M

Float Shares:17.66M

Volume Ratio:0.05

T/O Rate:0.01%

Dividend:- -

Dividend Rate:- -

EPS(TTM):-1.2317

EPS(LYR):-1.5361

ROE:--

ROA:-93.33%

PB:-0.16

PE(LYR):-0.04

Loading ...

Overview Company News Filings

Major Issues Report

Form 8-K - Current report

Major Issues Report

Form 8-K - Current report

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

Major Issues Report

Form 8-K - Current report

Major Issues Report

Form 8-K - Current report

Annual Report

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]

Major Issues Report

Form 8-K - Current report

Major Issues Report

Form 8-K - Current report

Major Issues Report

Form 8-K - Current report

Major Issues Report

Form 8-K - Current report

Delisting

Form 25-NSE - Notification filed by national security exchange to report the removal from listing and registration of matured, redeemed or retired securities

Major Issues Report

Form 8-K - Current report

Major Issues Report

Form 8-K - Current report

Major Issues Report

Form 8-K - Current report

Major Issues Report

Form 8-K - Current report

Major Issues Report

Form 8-K - Current report

Major Issues Report

Form 8-K - Current report

Major Issues Report

Form 8-K - Current report

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

Major Issues Report

Form 8-K - Current report

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/NKGN/filings"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"NKGN","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"NKGN\",,,,,undefined,":{"symbol":"NKGN","market":"US","secType":"STK","nameCN":"NKGen Biotech Inc.","latestPrice":0.06,"timestamp":1770757200000,"preClose":0.06,"halted":0,"volume":1001,"delay":15,"changeRate":0,"floatShares":17655663,"shares":130602230,"eps":-1.231688,"marketStatus":"Closed","change":0,"latestTime":"02-10 16:00:00 EST Delay","open":0.06,"high":0.06,"low":0.06,"amount":60.06,"amplitude":0,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"otc":true,"ttmEps":-1.231688,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1770800400000},"marketStatusCode":5,"adr":0,"exchange":"EXPERT","adjPreClose":0.06,"volumeRatio":0.04553},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"NKGN\",,,,,undefined,":{"symbol":"NKGN","floatShares":17655663,"roa":"-93.33%","roe":"--","lyrEps":-1.536089,"volumeRatio":0.04553,"shares":130602230,"dividePrice":0,"high":0.06,"amplitude":0,"preClose":0.06,"low":0.06,"week52Low":0.0002,"pbRate":"-0.16","week52High":0.91,"institutionHeld":0,"latestPrice":0.06,"eps":-1.231688,"divideRate":0,"volume":1001,"delay":15,"ttmEps":-1.231688,"open":0.06,"prevYearClose":0.05,"prevWeekClose":0.06,"prevMonthClose":0.06,"prevQuarterClose":0.05,"fiveDayClose":0.06,"twentyDayClose":0.06,"sixtyDayClose":0.02},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/NKGN\",params:#limit:5,,,undefined,":[{"market":"US","date":"2025-03-05","symbol":"NKGN","reason":null,"defaultRemindTime":1741185000000,"announcedDate":"2025-03-04","type":"delisting","dateTimestamp":1741150800000},{"market":"US","date":"2024-09-12","symbol":"NKGN","fiscalQuarterEnding":"2024/06","expectedEps":null,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1726113600000,"reportTimeType":"post","actualEps":-0.67},{"market":"US","date":"2024-05-20","symbol":"NKGN","fiscalQuarterEnding":"2024/03","expectedEps":null,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1716177600000,"reportTimeType":"post","actualEps":-0.25},{"market":"US","date":"2024-04-16","symbol":"NKGN","fiscalQuarterEnding":"2023/12","expectedEps":null,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1713240000000,"reportTimeType":"post","actualEps":-1.68},{"market":"US","date":"2023-11-14","symbol":"NKGN","fiscalQuarterEnding":"2023/09","expectedEps":null,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1699938000000,"reportTimeType":"post","actualEps":-2.48}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"NKGN\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"NKGN\",market:\"US\",delay:false,,,undefined,":{},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/NKGN\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"NKGN","date":"2025-03-03","current":-0.271714,"percent":0.653374,"low":-3.085872,"twenty":-1.017152,"median":-0.369534,"eighty":-0.200359,"high":-0.092159,"avg":-0.615092,"sd":0.608265,"marketCap":23979538},"quantilePoints":[{"date":"2023-10-13","current":-2.180674,"twenty":-2.944804,"median":-2.349548,"eighty":-2.292278,"marketCap":65010258},{"date":"2023-10-20","current":-2.202701,"twenty":-2.461546,"median":-2.202701,"eighty":-2.198296,"marketCap":65666928},{"date":"2023-10-27","current":-2.775403,"twenty":-2.690232,"median":-2.202701,"eighty":-2.196827,"marketCap":82740329},{"date":"2023-11-03","current":-2.239413,"twenty":-2.543386,"median":-2.202701,"eighty":-2.183611,"marketCap":66761376},{"date":"2023-11-10","current":-2.276125,"twenty":-2.411223,"median":-2.257769,"eighty":-2.196827,"marketCap":67855825},{"date":"2023-11-17","current":-2.114593,"twenty":-2.362764,"median":-2.202701,"eighty":-2.138088,"marketCap":63040250},{"date":"2023-11-24","current":-1.139241,"twenty":-2.35689,"median":-2.202701,"eighty":-2.099908,"marketCap":64134699},{"date":"2023-12-01","current":-1.341388,"twenty":-2.349548,"median":-2.188016,"eighty":-1.310321,"marketCap":75514778},{"date":"2023-12-08","current":-1.321986,"twenty":-2.334863,"median":-2.143962,"eighty":-1.283104,"marketCap":74422518},{"date":"2023-12-15","current":-1.463905,"twenty":-2.320179,"median":-2.110922,"eighty":-1.310321,"marketCap":82411994},{"date":"2023-12-22","current":-1.100359,"twenty":-2.276125,"median":-2.063931,"eighty":-1.197564,"marketCap":61945802},{"date":"2023-12-29","current":-1.193676,"twenty":-2.254098,"median":-1.734182,"eighty":-1.172679,"marketCap":67199156},{"date":"2024-01-05","current":-1.073141,"twenty":-2.239413,"median":-1.426967,"eighty":-1.161793,"marketCap":60413573},{"date":"2024-01-12","current":-1.042036,"twenty":-2.232071,"median":-1.331687,"eighty":-1.123688,"marketCap":58662455},{"date":"2024-01-19","current":-0.989545,"twenty":-2.202701,"median":-1.318097,"eighty":-1.096471,"marketCap":55707443},{"date":"2024-01-26","current":-0.913726,"twenty":-2.202701,"median":-1.312265,"eighty":-1.073141,"marketCap":51439093},{"date":"2024-02-02","current":-0.624055,"twenty":-2.202701,"median":-1.304489,"eighty":-1.065365,"marketCap":35131806},{"date":"2024-02-09","current":-0.625999,"twenty":-2.202701,"median":-1.197564,"eighty":-1.022595,"marketCap":35241251},{"date":"2024-02-16","current":-0.585173,"twenty":-2.195359,"median":-1.180067,"eighty":-0.989545,"marketCap":32942908},{"date":"2024-02-23","current":-0.388819,"twenty":-2.183611,"median":-1.166459,"eighty":-0.878514,"marketCap":21888976},{"date":"2024-03-01","current":-0.309889,"twenty":-2.157179,"median":-1.139241,"eighty":-0.629887,"marketCap":17445513},{"date":"2024-03-08","current":-0.750421,"twenty":-2.145431,"median":-1.115911,"eighty":-0.62561,"marketCap":42245723},{"date":"2024-03-15","current":-0.723204,"twenty":-2.138088,"median":-1.096471,"eighty":-0.629109,"marketCap":40713495},{"date":"2024-03-22","current":-0.863179,"twenty":-2.118998,"median":-1.079771,"eighty":-0.629887,"marketCap":48593526},{"date":"2024-03-28","current":-0.699875,"twenty":-2.110188,"median":-1.071197,"eighty":-0.63222,"marketCap":39400156},{"date":"2024-04-05","current":-0.503373,"twenty":-2.102845,"median":-1.065365,"eighty":-0.629887,"marketCap":28337889},{"date":"2024-04-12","current":-0.503373,"twenty":-2.078322,"median":-1.053701,"eighty":-0.610089,"marketCap":28337889},{"date":"2024-04-19","current":-0.338204,"twenty":-2.028247,"median":-1.022595,"eighty":-0.596449,"marketCap":19039519},{"date":"2024-04-26","current":-0.54434,"twenty":-1.680126,"median":-1.008986,"eighty":-0.567673,"marketCap":45155173},{"date":"2024-05-03","current":-0.362893,"twenty":-1.441742,"median":-0.989545,"eighty":-0.506509,"marketCap":30103448},{"date":"2024-05-10","current":-0.343649,"twenty":-1.375643,"median":-0.907894,"eighty":-0.49327,"marketCap":28507053},{"date":"2024-05-17","current":-0.320045,"twenty":-1.341404,"median":-0.877643,"eighty":-0.471192,"marketCap":26548978},{"date":"2024-05-24","current":-0.546156,"twenty":-1.329747,"median":-0.84957,"eighty":-0.471192,"marketCap":43700088},{"date":"2024-05-31","current":-0.488338,"twenty":-1.321986,"median":-0.832073,"eighty":-0.458565,"marketCap":39073844},{"date":"2024-06-07","current":-0.426129,"twenty":-1.318875,"median":-0.765974,"eighty":-0.449088,"marketCap":34096284},{"date":"2024-06-14","current":-0.410577,"twenty":-1.314209,"median":-0.762086,"eighty":-0.443054,"marketCap":32851894},{"date":"2024-06-21","current":-0.373252,"twenty":-1.314209,"median":-0.746533,"eighty":-0.419908,"marketCap":29865358},{"date":"2024-06-28","current":-0.385693,"twenty":-1.313431,"median":-0.743262,"eighty":-0.41586,"marketCap":30860870},{"date":"2024-07-05","current":-0.407466,"twenty":-1.311876,"median":-0.715734,"eighty":-0.407466,"marketCap":32603016},{"date":"2024-07-12","current":-0.323485,"twenty":-1.309543,"median":-0.686267,"eighty":-0.404316,"marketCap":25883310},{"date":"2024-07-15","current":-0.298601,"twenty":-1.308766,"median":-0.672658,"eighty":-0.402482,"marketCap":23892287},{"date":"2024-08-02","current":-0.344629,"twenty":-1.307988,"median":-0.662937,"eighty":-0.401328,"marketCap":27575111},{"date":"2024-08-09","current":-0.328524,"twenty":-1.3041,"median":-0.629887,"eighty":-0.395025,"marketCap":26286554},{"date":"2024-08-16","current":-0.281822,"twenty":-1.29088,"median":-0.625027,"eighty":-0.387569,"marketCap":22549740},{"date":"2024-08-23","current":-0.257988,"twenty":-1.23178,"median":-0.609553,"eighty":-0.372408,"marketCap":20642676},{"date":"2024-08-30","current":-0.245878,"twenty":-1.195231,"median":-0.60267,"eighty":-0.368424,"marketCap":19673682},{"date":"2024-09-06","current":-0.246103,"twenty":-1.18901,"median":-0.586145,"eighty":-0.359064,"marketCap":19691721},{"date":"2024-09-13","current":-0.280405,"twenty":-1.180456,"median":-0.583229,"eighty":-0.344629,"marketCap":22436347},{"date":"2024-09-20","current":-0.171296,"twenty":-1.176568,"median":-0.54352,"eighty":-0.33213,"marketCap":15117415},{"date":"2024-09-27","current":-0.158394,"twenty":-1.168014,"median":-0.519442,"eighty":-0.32312,"marketCap":13978747},{"date":"2024-10-04","current":-0.15587,"twenty":-1.150906,"median":-0.512641,"eighty":-0.317872,"marketCap":13755964},{"date":"2024-10-11","current":-0.115199,"twenty":-1.139241,"median":-0.503373,"eighty":-0.311624,"marketCap":10166683},{"date":"2024-10-18","current":-0.285679,"twenty":-1.139241,"median":-0.49881,"eighty":-0.304184,"marketCap":25212023},{"date":"2024-10-25","current":-0.15798,"twenty":-1.131465,"median":-0.489912,"eighty":-0.283365,"marketCap":13942248},{"date":"2024-10-31","current":-0.117128,"twenty":-1.118245,"median":-0.487643,"eighty":-0.276991,"marketCap":10336929},{"date":"2024-11-08","current":-0.110272,"twenty":-1.10969,"median":-0.473878,"eighty":-0.260707,"marketCap":9731840},{"date":"2024-11-15","current":-0.113088,"twenty":-1.099581,"median":-0.451012,"eighty":-0.251399,"marketCap":9980359},{"date":"2024-11-22","current":-0.137738,"twenty":-1.094916,"median":-0.449385,"eighty":-0.246161,"marketCap":12155796},{"date":"2024-11-29","current":-0.163245,"twenty":-1.088694,"median":-0.443706,"eighty":-0.241369,"marketCap":14406870},{"date":"2024-12-06","current":-0.183569,"twenty":-1.080918,"median":-0.426129,"eighty":-0.205158,"marketCap":16200525},{"date":"2024-12-13","current":-0.201934,"twenty":-1.078624,"median":-0.416878,"eighty":-0.201567,"marketCap":17821298},{"date":"2024-12-20","current":-0.230625,"twenty":-1.073141,"median":-0.415128,"eighty":-0.198751,"marketCap":20353306},{"date":"2024-12-27","current":-0.356731,"twenty":-1.070031,"median":-0.407466,"eighty":-0.199796,"marketCap":31482613},{"date":"2025-01-03","current":-0.282006,"twenty":-1.069253,"median":-0.405058,"eighty":-0.200963,"marketCap":24887868},{"date":"2025-01-10","current":-0.233645,"twenty":-1.067698,"median":-0.401382,"eighty":-0.201714,"marketCap":20619833},{"date":"2025-01-17","current":-0.187977,"twenty":-1.065365,"median":-0.401246,"eighty":-0.19973,"marketCap":16589511},{"date":"2025-01-24","current":-0.212259,"twenty":-1.063032,"median":-0.395025,"eighty":-0.198914,"marketCap":18732533},{"date":"2025-01-31","current":-0.248031,"twenty":-1.053701,"median":-0.388819,"eighty":-0.199649,"marketCap":21889475},{"date":"2025-02-07","current":-0.229187,"twenty":-1.051368,"median":-0.37948,"eighty":-0.199991,"marketCap":20226414},{"date":"2025-02-14","current":-0.391604,"twenty":-1.038148,"median":-0.373267,"eighty":-0.199649,"marketCap":34560200},{"date":"2025-02-21","current":-0.228168,"twenty":-1.022595,"median":-0.373252,"eighty":-0.199975,"marketCap":20136519},{"date":"2025-02-28","current":-0.272579,"twenty":-1.018707,"median":-0.369837,"eighty":-0.200057,"marketCap":24055949},{"date":"2025-03-03","current":-0.271714,"twenty":-1.017152,"median":-0.369534,"eighty":-0.200359,"marketCap":23979538}],"updateTime":1770768803263},"$inf$@#url:\"https://stock-news.skytigris.cn/v3/notice/important/events/list\",params:#symbol:\"NKGN\",pageSize:20,pageCount:1,market:\"us\",,,undefined,":[{"items":[{"cdn_pdf":false,"hasAttachments":true,"id":"20705946","market":"us","labels":[],"media":"sec.gov","original_id":"AN121390026012879-NKGN","pdf_url":"","pub_time":1770267600000,"showTitleType":true,"size":0,"source":"sec_us","summary":"Form 8-K - Current report","symbol":"NKGN","title":"Form 8-K - Current report","titleType":"Major Issues Report","type":"usAnnouncement","url":"https://www.sec.gov/Archives/edgar/data/1845459/000121390026012879/0001213900-26-012879-index.htm","us_notice_code":"Form 8-K","us_title_en":"Item 1.01: Entry into a Material Definitive Agreement;\nItem 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant;\nItem 9.01: Financial Statements and Exhibits","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","attachments":[{"description":"AMENDMENT NO. 3 TO SECURED PROMISSORY NOTE ISSUED TO THE ALPINEBROOK CAPITAL GP","seq":1,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1845459/000121390026012879/ea027535001ex10-1_nkgen.htm","primary":true,"translateUrl":"","linkName":"ea027535001ex10-1_nkgen.htm","type":"EX-10.1","id":"NTFILE4mown1XRxxDY7YhD","market":"us","size":19058},{"description":"CURRENT REPORT","seq":2,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1845459/000121390026012879/ea0275350-8k_nkgen.htm","primary":false,"translateUrl":"","linkName":"ea0275350-8k_nkgen.htm","type":"8-K","id":"NTFILEJ4cxnpjNwMuGQ3PY","market":"us","size":28754}],"type_name":"Transaction Related","type_name_en":"Transaction Related","titleTypeEn":"Major Issues Report","us_type":"交易披露","us_type_zh":"交易披露","earn_infos":[],"event_type":"important_notice","event_name":"Major Issues Report","pubTime":"2026-02-05 13:00","pubTimestamp":1770267600,"title_zh":"Form 8-K - Current report","summary_en":"Item 1.01: Entry into a Material Definitive Agreement;\nItem 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant;\nItem 9.01: Financial Statements and Exhibits","summary_zh":"","notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":false,"hasAttachments":true,"id":"20664297","market":"us","labels":[],"media":"sec.gov","original_id":"AN121390026007794-NKGN","pdf_url":"","pub_time":1769403600000,"showTitleType":true,"size":0,"source":"sec_us","summary":"Form 8-K - Current report","symbol":"NKGN","title":"Form 8-K - Current report","titleType":"Major Issues Report","type":"usAnnouncement","url":"https://www.sec.gov/Archives/edgar/data/1845459/000121390026007794/0001213900-26-007794-index.htm","us_notice_code":"Form 8-K","us_title_en":"Item 1.01: Entry into a Material Definitive Agreement;\nItem 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant;\nItem 9.01: Financial Statements and Exhibits","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","attachments":[{"description":"EIGHTH AMENDMENT TO FORWARD PURCHASE AGREEMENT, DATED AS OF JANUARY 20, 2026, AM","seq":1,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1845459/000121390026007794/ea027345101ex10-1_nkgen.htm","primary":true,"translateUrl":"","linkName":"ea027345101ex10-1_nkgen.htm","type":"EX-10.1","id":"NTFILE2sFQTo38d85pm2U2","market":"us","size":12735},{"description":"CURRENT REPORT","seq":2,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1845459/000121390026007794/ea0273451-8k_nkgen.htm","primary":false,"translateUrl":"","linkName":"ea0273451-8k_nkgen.htm","type":"8-K","id":"NTFILE2aZAtBZVni8BGE5f","market":"us","size":31060},{"description":"AMENDMENT NO. 2 TO SECURED PROMISSORY NOTE ISSUED TO THE ALPINEBROOK CAPITAL GP","seq":3,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1845459/000121390026007794/ea027345101ex10-2_nkgen.htm","primary":false,"translateUrl":"","linkName":"ea027345101ex10-2_nkgen.htm","type":"EX-10.2","id":"NTFILEBrB1xmgn8yXVNqoX","market":"us","size":23009}],"type_name":"Transaction Related","type_name_en":"Transaction Related","titleTypeEn":"Major Issues Report","us_type":"交易披露","us_type_zh":"交易披露","earn_infos":[],"event_type":"important_notice","event_name":"Major Issues Report","pubTime":"2026-01-26 13:00","pubTimestamp":1769403600,"title_zh":"Form 8-K - Current report","summary_en":"Item 1.01: Entry into a Material Definitive Agreement;\nItem 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant;\nItem 9.01: Financial Statements and Exhibits","summary_zh":"","notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":false,"hasAttachments":true,"id":"20645093","market":"us","labels":[],"media":"sec.gov","original_id":"AN184545926000003-NKGN","pdf_url":"","pub_time":1768885200000,"showTitleType":true,"size":0,"source":"sec_us","summary":"Form 10-Q - Quarterly report [Sections 13 or 15(d)]","symbol":"NKGN","title":"Form 10-Q - Quarterly report [Sections 13 or 15(d)]","titleType":"Quarterly Report","type":"usFinancials","url":"https://www.sec.gov/Archives/edgar/data/1845459/000184545926000003/0001845459-26-000003-index.htm","us_notice_code":"Form 10-Q","us_title_en":"Form 10-Q - Quarterly report [Sections 13 or 15(d)]","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","attachments":[{"description":"10-Q","seq":1,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1845459/000184545926000003/nkgn-20250331.htm","primary":true,"translateUrl":"","linkName":"nkgn-20250331.htm","type":"10-Q","id":"NTFILEDJX4Ao43ozpwzPw7","market":"us","size":1674919},{"description":"EX-31.1","seq":2,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1845459/000184545926000003/nkgenbiotechinc-ex311q12025.htm","primary":false,"translateUrl":"","linkName":"nkgenbiotechinc-ex311q12025.htm","type":"EX-31.1","id":"NTFILE6Y6QaepaUyjHvdPF","market":"us","size":8232},{"description":"EX-31.2","seq":3,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1845459/000184545926000003/nkgenbiotechinc-ex312q12025.htm","primary":false,"translateUrl":"","linkName":"nkgenbiotechinc-ex312q12025.htm","type":"EX-31.2","id":"NTFILE6omyQSzXEaXVzg78","market":"us","size":8266},{"description":"EX-32.1","seq":4,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1845459/000184545926000003/nkgenbiotechinc-ex321q12025.htm","primary":false,"translateUrl":"","linkName":"nkgenbiotechinc-ex321q12025.htm","type":"EX-32.1","id":"NTFILE2T7bNAyfbox3tUg5","market":"us","size":7024}],"type_name":"Financial Report","type_name_en":"Financial Report","titleTypeEn":"Quarterly Report","us_type":"财务报告","us_type_zh":"财务报告","earn_infos":[],"event_type":"important_notice","event_name":"Quarterly Report","pubTime":"2026-01-20 13:00","pubTimestamp":1768885200,"title_zh":"Form 10-Q - Quarterly report [Sections 13 or 15(d","summary_en":"","summary_zh":"","notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":false,"hasAttachments":true,"id":"20640688","market":"us","labels":[],"media":"sec.gov","original_id":"AN121390026005260-NKGN","pdf_url":"","pub_time":1768539600000,"showTitleType":true,"size":0,"source":"sec_us","summary":"Form 8-K - Current report","symbol":"NKGN","title":"Form 8-K - Current report","titleType":"Major Issues Report","type":"usAnnouncement","url":"https://www.sec.gov/Archives/edgar/data/1845459/000121390026005260/0001213900-26-005260-index.htm","us_notice_code":"Form 8-K","us_title_en":"Item 1.01: Entry into a Material Definitive Agreement;\nItem 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant;\nItem 9.01: Financial Statements and Exhibits","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","attachments":[{"description":"AMENDMENT TO SECURED PROMISSORY NOTE ISSUED TO THE ALPINEBROOK CAPITAL GP I LIMI","seq":1,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1845459/000121390026005260/ea027256601ex10-1_nkgen.htm","primary":true,"translateUrl":"","linkName":"ea027256601ex10-1_nkgen.htm","type":"EX-10.1","id":"NTFILE5GbCnHdGZdGd1fUS","market":"us","size":17273},{"description":"CURRENT REPORT","seq":2,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1845459/000121390026005260/ea0272566-8k_nkgen.htm","primary":false,"translateUrl":"","linkName":"ea0272566-8k_nkgen.htm","type":"8-K","id":"NTFILE7fjaKqSRQtRxeqwd","market":"us","size":29489}],"type_name":"Transaction Related","type_name_en":"Transaction Related","titleTypeEn":"Major Issues Report","us_type":"交易披露","us_type_zh":"交易披露","earn_infos":[],"event_type":"important_notice","event_name":"Major Issues Report","pubTime":"2026-01-16 13:00","pubTimestamp":1768539600,"title_zh":"Form 8-K - Current report","summary_en":"Item 1.01: Entry into a Material Definitive Agreement;\nItem 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant;\nItem 9.01: Financial Statements and Exhibits","summary_zh":"","notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":false,"hasAttachments":true,"id":"20621235","market":"us","labels":[],"media":"sec.gov","original_id":"AN121390026003030-NKGN","pdf_url":"","pub_time":1767934800000,"showTitleType":true,"size":0,"source":"sec_us","summary":"Form 8-K - Current report","symbol":"NKGN","title":"Form 8-K - Current report","titleType":"Major Issues Report","type":"usAnnouncement","url":"https://www.sec.gov/Archives/edgar/data/1845459/000121390026003030/0001213900-26-003030-index.htm","us_notice_code":"Form 8-K","us_title_en":"Item 1.01: Entry into a Material Definitive Agreement;\nItem 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant;\nItem 9.01: Financial Statements and Exhibits","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","attachments":[{"description":"SECURED PROMISSORY NOTE ISSUED TO THE ALPINEBROOK CAPITAL GP I LIMITED, DATED JA","seq":1,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1845459/000121390026003030/ea027206101ex10-1_nkgen.htm","primary":true,"translateUrl":"","linkName":"ea027206101ex10-1_nkgen.htm","type":"EX-10.1","id":"NTFILEExwyp9RsmMTBwapp","market":"us","size":97180},{"description":"CURRENT REPORT","seq":2,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1845459/000121390026003030/ea0272061-8k_nkgen.htm","primary":false,"translateUrl":"","linkName":"ea0272061-8k_nkgen.htm","type":"8-K","id":"NTFILECjKeaTggEmaKD3U2","market":"us","size":35918}],"type_name":"Transaction Related","type_name_en":"Transaction Related","titleTypeEn":"Major Issues Report","us_type":"交易披露","us_type_zh":"交易披露","earn_infos":[],"event_type":"important_notice","event_name":"Major Issues Report","pubTime":"2026-01-09 13:00","pubTimestamp":1767934800,"title_zh":"Form 8-K - Current report","summary_en":"Item 1.01: Entry into a Material Definitive Agreement;\nItem 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant;\nItem 9.01: Financial Statements and Exhibits","summary_zh":"","notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":false,"hasAttachments":true,"id":"20247725","market":"us","labels":[],"media":"sec.gov","original_id":"AN184545925000004-NKGN","pdf_url":"","pub_time":1759872993000,"showTitleType":true,"size":0,"source":"sec_us","summary":"Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]","symbol":"NKGN","title":"Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]","titleType":"Annual Report","type":"usFinancials","url":"https://www.sec.gov/Archives/edgar/data/1845459/0001845459-25-000004-index.html","us_notice_code":"Form 10-K","us_title_en":"Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","attachments":[{"description":"10-K","seq":1,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1845459/000184545925000004/nkgn-20241231.htm","primary":true,"translateUrl":"","linkName":"nkgn-20241231.htm","type":"10-K","id":"NTFILEADZe3MVsyyipRJuj","market":"us","size":3479626},{"description":"EX-31.1","seq":2,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1845459/000184545925000004/nkgenbiotechinc-exhibit3114.htm","primary":false,"translateUrl":"","linkName":"nkgenbiotechinc-exhibit3114.htm","type":"EX-31.1","id":"NTFILEZmYdhmiYa7qYFK78","market":"us","size":8230},{"description":"EX-31.2","seq":3,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1845459/000184545925000004/nkgenbiotechinc-exhibit3124.htm","primary":false,"translateUrl":"","linkName":"nkgenbiotechinc-exhibit3124.htm","type":"EX-31.2","id":"NTFILE5dBuukNX7PQPVp7x","market":"us","size":8266},{"description":"EX-32.1","seq":4,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1845459/000184545925000004/nkgenbiotechinc-exhibit3213.htm","primary":false,"translateUrl":"","linkName":"nkgenbiotechinc-exhibit3213.htm","type":"EX-32.1","id":"NTFILEB876LmguKDQ3g89h","market":"us","size":6472},{"description":"","seq":10,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1845459/000184545925000004/nkgn-20241231_g1.jpg","primary":false,"translateUrl":"","linkName":"nkgn-20241231_g1.jpg","type":"GRAPHIC","id":"NTFILEv7Ttf5CeE22YUkZe","market":"us","size":104177},{"description":"","seq":11,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1845459/000184545925000004/nkgn-20241231_g10.jpg","primary":false,"translateUrl":"","linkName":"nkgn-20241231_g10.jpg","type":"GRAPHIC","id":"NTFILEGqo3krUwvttZbM1v","market":"us","size":89019},{"description":"","seq":12,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1845459/000184545925000004/nkgn-20241231_g2.jpg","primary":false,"translateUrl":"","linkName":"nkgn-20241231_g2.jpg","type":"GRAPHIC","id":"NTFILE3hxibSeAj39BR9CH","market":"us","size":123869},{"description":"","seq":13,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1845459/000184545925000004/nkgn-20241231_g3.jpg","primary":false,"translateUrl":"","linkName":"nkgn-20241231_g3.jpg","type":"GRAPHIC","id":"NTFILE642DW6BEASEkgmAc","market":"us","size":71126},{"description":"","seq":14,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1845459/000184545925000004/nkgn-20241231_g4.jpg","primary":false,"translateUrl":"","linkName":"nkgn-20241231_g4.jpg","type":"GRAPHIC","id":"NTFILE4g7iUZRgoDbLcsiq","market":"us","size":78935},{"description":"","seq":15,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1845459/000184545925000004/nkgn-20241231_g5.jpg","primary":false,"translateUrl":"","linkName":"nkgn-20241231_g5.jpg","type":"GRAPHIC","id":"NTFILEXKNEYSATKxqA8Bb4","market":"us","size":68317},{"description":"","seq":16,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1845459/000184545925000004/nkgn-20241231_g6.jpg","primary":false,"translateUrl":"","linkName":"nkgn-20241231_g6.jpg","type":"GRAPHIC","id":"NTFILE4r2V1Mvv9HaxNndN","market":"us","size":83673},{"description":"","seq":17,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1845459/000184545925000004/nkgn-20241231_g7.jpg","primary":false,"translateUrl":"","linkName":"nkgn-20241231_g7.jpg","type":"GRAPHIC","id":"NTFILE3vDtkYhFvkk8jW1i","market":"us","size":46726},{"description":"","seq":18,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1845459/000184545925000004/nkgn-20241231_g8.jpg","primary":false,"translateUrl":"","linkName":"nkgn-20241231_g8.jpg","type":"GRAPHIC","id":"NTFILEEBBEAZE69ZXDgLbG","market":"us","size":73540},{"description":"","seq":19,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1845459/000184545925000004/nkgn-20241231_g9.jpg","primary":false,"translateUrl":"","linkName":"nkgn-20241231_g9.jpg","type":"GRAPHIC","id":"NTFILECT6mckRiU2otsSGT","market":"us","size":59956}],"type_name":"Financial Report","type_name_en":"Financial Report","titleTypeEn":"Annual Report","us_type":"财务报告","us_type_zh":"财务报告","earn_infos":[],"event_type":"important_notice","event_name":"Annual Report","pubTime":"2025-10-08 05:36","pubTimestamp":1759872993,"title_zh":"Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405","summary_en":"","summary_zh":"","notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":false,"hasAttachments":true,"id":"20222867","market":"us","labels":[],"media":"sec.gov","original_id":"AN121390025093062-NKGN","pdf_url":"","pub_time":1759118400000,"showTitleType":true,"size":0,"source":"sec_us","summary":"Form 8-K - Current report","symbol":"NKGN","title":"Form 8-K - Current report","titleType":"Major Issues Report","type":"usAnnouncement","url":"https://www.sec.gov/Archives/edgar/data/1845459/000121390025093062/0001213900-25-093062-index.htm","us_notice_code":"Form 8-K","us_title_en":"Item 1.01: Entry into a Material Definitive Agreement;\nItem 9.01: Financial Statements and Exhibits","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","attachments":[{"description":"CONSULTING AGREEMENT, BY AND BETWEEN NKGEN BIOTECH, INC. AND YOUNGMAN KIM, DATED","seq":1,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1845459/000121390025093062/ea025902901ex10-1_nkgen.htm","primary":true,"translateUrl":"","linkName":"ea025902901ex10-1_nkgen.htm","type":"EX-10.1","id":"NTFILE5Wm5fSRdaehmtDdp","market":"us","size":32145},{"description":"CURRENT REPORT","seq":2,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1845459/000121390025093062/ea0259029-8k_nkgen.htm","primary":false,"translateUrl":"","linkName":"ea0259029-8k_nkgen.htm","type":"8-K","id":"NTFILE9ZQaefegEcmvFkcz","market":"us","size":29174}],"type_name":"Transaction Related","type_name_en":"Transaction Related","titleTypeEn":"Major Issues Report","us_type":"交易披露","us_type_zh":"交易披露","earn_infos":[],"event_type":"important_notice","event_name":"Major Issues Report","pubTime":"2025-09-29 12:00","pubTimestamp":1759118400,"title_zh":"Form 8-K - Current report","summary_en":"Item 1.01: Entry into a Material Definitive Agreement;\nItem 9.01: Financial Statements and Exhibits","summary_zh":"","notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":false,"hasAttachments":true,"id":"20201800","market":"us","labels":[],"media":"sec.gov","original_id":"AN121390025091112-NKGN","pdf_url":"","pub_time":1758686400000,"showTitleType":true,"size":0,"source":"sec_us","summary":"Form 8-K - Current report","symbol":"NKGN","title":"Form 8-K - Current report","titleType":"Major Issues Report","type":"usAnnouncement","url":"https://www.sec.gov/Archives/edgar/data/1845459/000121390025091112/0001213900-25-091112-index.htm","us_notice_code":"Form 8-K","us_title_en":"Item 1.01: Entry into a Material Definitive Agreement;\nItem 3.02: Unregistered Sales of Equity Securities;\nItem 9.01: Financial Statements and Exhibits","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","attachments":[{"description":"COMMON STOCK PURCHASE WARRANT, DATED SEPTEMBER 18, 2025, BY AND BETWEEN NKGEN BI","seq":1,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1845459/000121390025091112/ea025828401ex4-1_nkgen.htm","primary":true,"translateUrl":"","linkName":"ea025828401ex4-1_nkgen.htm","type":"EX-4.1","id":"NTFILEGrkEn9Y1b8srP7vr","market":"us","size":107635},{"description":"CURRENT REPORT","seq":2,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1845459/000121390025091112/ea0258284-8k_nkgen.htm","primary":false,"translateUrl":"","linkName":"ea0258284-8k_nkgen.htm","type":"8-K","id":"NTFILE2n6rhs2vQgoEGBEX","market":"us","size":32005},{"description":"STOCK PURCHASE AGREEMENT, DATED SEPTEMBER 18, 2025, BY AND BETWEEN NKGEN BIOTECH","seq":3,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1845459/000121390025091112/ea025828401ex10-1_nkgen.htm","primary":false,"translateUrl":"","linkName":"ea025828401ex10-1_nkgen.htm","type":"EX-10.1","id":"NTFILE5vaFpHm7zPrRR2Mk","market":"us","size":189498},{"description":"LETTER AGREEMENT, DATED SEPTEMBER 18, 2025, BY AND BETWEEN NKGEN BIOTECH, INC. A","seq":4,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1845459/000121390025091112/ea025828401ex10-2_nkgen.htm","primary":false,"translateUrl":"","linkName":"ea025828401ex10-2_nkgen.htm","type":"EX-10.2","id":"NTFILE7MiY1xKyKT61TybU","market":"us","size":32328}],"type_name":"Transaction Related","type_name_en":"Transaction Related","titleTypeEn":"Major Issues Report","us_type":"交易披露","us_type_zh":"交易披露","earn_infos":[],"event_type":"important_notice","event_name":"Major Issues Report","pubTime":"2025-09-24 12:00","pubTimestamp":1758686400,"title_zh":"Form 8-K - Current report","summary_en":"Item 1.01: Entry into a Material Definitive Agreement;\nItem 3.02: Unregistered Sales of Equity Securities;\nItem 9.01: Financial Statements and Exhibits","summary_zh":"","notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":false,"hasAttachments":true,"id":"20147571","market":"us","labels":[],"media":"sec.gov","original_id":"AN121390025085858-NKGN","pdf_url":"","pub_time":1757390400000,"showTitleType":true,"size":0,"source":"sec_us","summary":"Form 8-K - Current report","symbol":"NKGN","title":"Form 8-K - Current report","titleType":"Major Issues Report","type":"usAnnouncement","url":"https://www.sec.gov/Archives/edgar/data/1845459/000121390025085858/0001213900-25-085858-index.htm","us_notice_code":"Form 8-K","us_title_en":"Item 2.01: Completion of Acquisition or Disposition of Assets;\nItem 7.01: Regulation FD Disclosure;\nItem 9.01: Financial Statements and Exhibits","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","attachments":[{"description":"PRESS RELEASE, DATED SEPTEMBER 9, 2025","seq":1,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1845459/000121390025085858/ea025655301ex99-1_nkgen.htm","primary":true,"translateUrl":"","linkName":"ea025655301ex99-1_nkgen.htm","type":"EX-99.1","id":"NTFILEBDnAyccvYREkZyGe","market":"us","size":17361},{"description":"CURRENT REPORT","seq":2,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1845459/000121390025085858/ea0256553-8k_nkgen.htm","primary":false,"translateUrl":"","linkName":"ea0256553-8k_nkgen.htm","type":"8-K","id":"NTFILE8Ydu1d1WKaHMy91f","market":"us","size":37408}],"type_name":"Transaction Related","type_name_en":"Transaction Related","titleTypeEn":"Major Issues Report","us_type":"交易披露","us_type_zh":"交易披露","earn_infos":[],"event_type":"important_notice","event_name":"Major Issues Report","pubTime":"2025-09-09 12:00","pubTimestamp":1757390400,"title_zh":"Form 8-K - Current report","summary_en":"Item 2.01: Completion of Acquisition or Disposition of Assets;\nItem 7.01: Regulation FD Disclosure;\nItem 9.01: Financial Statements and Exhibits","summary_zh":"","notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":false,"hasAttachments":true,"id":"19888592","market":"us","labels":[],"media":"sec.gov","original_id":"AN121390025065162-NKGN","pdf_url":"","pub_time":1752724800000,"showTitleType":true,"size":0,"source":"sec_us","summary":"Form 8-K - Current report","symbol":"NKGN","title":"Form 8-K - Current report","titleType":"Major Issues Report","type":"usAnnouncement","url":"https://www.sec.gov/Archives/edgar/data/1845459/000121390025065162/0001213900-25-065162-index.htm","us_notice_code":"Form 8-K","us_title_en":"Item 1.01: Entry into a Material Definitive Agreement;\nItem 7.01: Regulation FD Disclosure;\nItem 9.01: Financial Statements and Exhibits","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","attachments":[{"description":"COLLABORATION AGREEMENT, DATED JULY 14, 2025, BY AND BETWEEN NKGEN BIOTECH, INC.","seq":1,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1845459/000121390025065162/ea024941001ex10-1_nkgen.htm","primary":true,"translateUrl":"","linkName":"ea024941001ex10-1_nkgen.htm","type":"EX-10.1","id":"NTFILE9gnYG6o4BrmruEeq","market":"us","size":417772},{"description":"CURRENT REPORT","seq":2,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1845459/000121390025065162/ea0249410-8k_nkgen.htm","primary":false,"translateUrl":"","linkName":"ea0249410-8k_nkgen.htm","type":"8-K","id":"NTFILE2RLsoeiASZRazeT2","market":"us","size":33051},{"description":"PRESS RELEASE, DATED JULY 17, 2025","seq":3,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1845459/000121390025065162/ea024941001ex99-1_nkgen.htm","primary":false,"translateUrl":"","linkName":"ea024941001ex99-1_nkgen.htm","type":"EX-99.1","id":"NTFILECFRvtsyUrdcD4Rb3","market":"us","size":13669}],"type_name":"Transaction Related","type_name_en":"Transaction Related","titleTypeEn":"Major Issues Report","us_type":"交易披露","us_type_zh":"交易披露","earn_infos":[],"event_type":"important_notice","event_name":"Major Issues Report","pubTime":"2025-07-17 12:00","pubTimestamp":1752724800,"title_zh":"Form 8-K - Current report","summary_en":"Item 1.01: Entry into a Material Definitive Agreement;\nItem 7.01: Regulation FD Disclosure;\nItem 9.01: Financial Statements and Exhibits","summary_zh":"","notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":false,"hasAttachments":true,"id":"19888026","market":"us","labels":[],"media":"sec.gov","original_id":"AN135445725000685-NKGN","pdf_url":"","pub_time":1752724800000,"showTitleType":true,"size":0,"source":"sec_us","summary":"Form 25-NSE - Notification filed by national security exchange to report the removal from listing and registration of matured, redeemed or retired securities","symbol":"NKGN","title":"Form 25-NSE - Notification filed by national security exchange to report the removal from listing and registration of matured, redeemed or retired securities","titleType":"Delisting","type":"usAnnouncement","url":"https://www.sec.gov/Archives/edgar/data/1845459/000135445725000685/0001354457-25-000685-index.htm","us_notice_code":"Form 25-NSE","us_title_en":"Form 25-NSE - Notification filed by national security exchange to report the removal from listing and registration of matured, redeemed or retired securities","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","attachments":[{"description":"","seq":1,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1354457/000135445725000685/xslF25X02/primary_doc.xml","primary":true,"translateUrl":"","linkName":"primary_doc.html","type":"25-NSE","id":"NTFILEUeLrpRMrxKW5d5RD","market":"us","size":0}],"type_name":"Transaction Related","type_name_en":"Transaction Related","titleTypeEn":"Delisting","us_type":"交易披露","us_type_zh":"交易披露","earn_infos":[],"event_type":"important_notice","event_name":"Delisting","pubTime":"2025-07-17 12:00","pubTimestamp":1752724800,"title_zh":"Form 25-NSE - Notification filed by national security exchange to report the removal from listing and registration of matured, redeemed or retired securities","summary_en":"","summary_zh":"","notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":false,"hasAttachments":true,"id":"19885206","market":"us","labels":[],"media":"sec.gov","original_id":"AN121390025064774-NKGN","pdf_url":"","pub_time":1752638400000,"showTitleType":true,"size":0,"source":"sec_us","summary":"Form 8-K - Current report","symbol":"NKGN","title":"Form 8-K - Current report","titleType":"Major Issues Report","type":"usAnnouncement","url":"https://www.sec.gov/Archives/edgar/data/1845459/000121390025064774/0001213900-25-064774-index.htm","us_notice_code":"Form 8-K","us_title_en":"Item 1.01: Entry into a Material Definitive Agreement;\nItem 3.02: Unregistered Sales of Equity Securities;\nItem 7.01: Regulation FD Disclosure;\nItem 8.01: Other Events;\nItem 9.01: Financial Statements and Exhibits","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","attachments":[{"description":"COMMON STOCK PURCHASE WARRANT, DATED JULY 14, 2025, BY AND BETWEEN NKGEN BIOTECH","seq":1,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1845459/000121390025064774/ea024923001ex4-1_nkgen.htm","primary":true,"translateUrl":"","linkName":"ea024923001ex4-1_nkgen.htm","type":"EX-4.1","id":"NTFILE4F1sx5dWjgw1BfMT","market":"us","size":133530},{"description":"CURRENT REPORT","seq":2,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1845459/000121390025064774/ea0249230-8k_nkgen.htm","primary":false,"translateUrl":"","linkName":"ea0249230-8k_nkgen.htm","type":"8-K","id":"NTFILEE241YNbDwJdSdkQE","market":"us","size":36229},{"description":"STOCK PURCHASE AGREEMENT, DATED JULY 14, 2025, BY AND BETWEEN NKGEN BIOTECH, INC","seq":3,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1845459/000121390025064774/ea024923001ex10-1_nkgen.htm","primary":false,"translateUrl":"","linkName":"ea024923001ex10-1_nkgen.htm","type":"EX-10.1","id":"NTFILE3rc6LQu1ZVwfyWah","market":"us","size":200413},{"description":"PRESS RELEASE, DATED JULY 16, 2025","seq":4,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1845459/000121390025064774/ea024923001ex99-1_nkgen.htm","primary":false,"translateUrl":"","linkName":"ea024923001ex99-1_nkgen.htm","type":"EX-99.1","id":"NTFILE14T74SWxH1PRPFsr","market":"us","size":14247}],"type_name":"Transaction Related","type_name_en":"Transaction Related","titleTypeEn":"Major Issues Report","us_type":"交易披露","us_type_zh":"交易披露","earn_infos":[],"event_type":"important_notice","event_name":"Major Issues Report","pubTime":"2025-07-16 12:00","pubTimestamp":1752638400,"title_zh":"Form 8-K - Current report","summary_en":"Item 1.01: Entry into a Material Definitive Agreement;\nItem 3.02: Unregistered Sales of Equity Securities;\nItem 7.01: Regulation FD Disclosure;\nItem 8.01: Other Events;\nItem 9.01: Financial Statements and Exhibits","summary_zh":"","notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":false,"hasAttachments":true,"id":"19792304","market":"us","labels":[],"media":"sec.gov","original_id":"AN121390025055833-NKGN","pdf_url":"","pub_time":1750392000000,"showTitleType":true,"size":0,"source":"sec_us","summary":"Form 8-K - Current report","symbol":"NKGN","title":"Form 8-K - Current report","titleType":"Major Issues Report","type":"usAnnouncement","url":"https://www.sec.gov/Archives/edgar/data/1845459/000121390025055833/0001213900-25-055833-index.htm","us_notice_code":"Form 8-K","us_title_en":"Item 8.01: Other Events;\nItem 9.01: Financial Statements and Exhibits","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","attachments":[{"description":"CURRENT REPORT","seq":1,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1845459/000121390025055833/ea0246125-8k_nkgen.htm","primary":true,"translateUrl":"","linkName":"ea0246125-8k_nkgen.htm","type":"8-K","id":"NTFILEEGGZuNneehKBZyZW","market":"us","size":33184}],"type_name":"Transaction Related","type_name_en":"Transaction Related","titleTypeEn":"Major Issues Report","us_type":"交易披露","us_type_zh":"交易披露","earn_infos":[],"event_type":"important_notice","event_name":"Major Issues Report","pubTime":"2025-06-20 12:00","pubTimestamp":1750392000,"title_zh":"Form 8-K - Current report","summary_en":"Item 8.01: Other Events;\nItem 9.01: Financial Statements and Exhibits","summary_zh":"","notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":false,"hasAttachments":true,"id":"19671338","market":"us","labels":[],"media":"sec.gov","original_id":"AN121390025045648-NKGN","pdf_url":"","pub_time":1747713600000,"showTitleType":true,"size":0,"source":"sec_us","summary":"Form 8-K - Current report","symbol":"NKGN","title":"Form 8-K - Current report","titleType":"Major Issues Report","type":"usAnnouncement","url":"https://www.sec.gov/Archives/edgar/data/1845459/000121390025045648/0001213900-25-045648-index.htm","us_notice_code":"Form 8-K","us_title_en":"Item 1.01: Entry into a Material Definitive Agreement;\nItem 3.02: Unregistered Sales of Equity Securities;\nItem 9.01: Financial Statements and Exhibits","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","attachments":[{"description":"COMMON STOCK PURCHASE WARRANT, DATED MAY 14, 2025, BY AND BETWEEN NKGEN BIOTECH,","seq":1,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1845459/000121390025045648/ea024261401ex4-1_nkgen.htm","primary":true,"translateUrl":"","linkName":"ea024261401ex4-1_nkgen.htm","type":"EX-4.1","id":"NTFILE2Ausd89Jc2r2ptKN","market":"us","size":136293},{"description":"CURRENT REPORT","seq":2,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1845459/000121390025045648/ea0242614-8k_nkgen.htm","primary":false,"translateUrl":"","linkName":"ea0242614-8k_nkgen.htm","type":"8-K","id":"NTFILEHziGY9DZePak6prf","market":"us","size":34100},{"description":"SECURITIES PURCHASE AGREEMENT, DATED MAY 14, 2025, BY AND BETWEEN NKGEN BIOTECH,","seq":3,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1845459/000121390025045648/ea024261401ex10-1_nkgen.htm","primary":false,"translateUrl":"","linkName":"ea024261401ex10-1_nkgen.htm","type":"EX-10.1","id":"NTFILEG9ktvPZCxqseb6un","market":"us","size":174808}],"type_name":"Transaction Related","type_name_en":"Transaction Related","titleTypeEn":"Major Issues Report","us_type":"交易披露","us_type_zh":"交易披露","earn_infos":[],"event_type":"important_notice","event_name":"Major Issues Report","pubTime":"2025-05-20 12:00","pubTimestamp":1747713600,"title_zh":"Form 8-K - Current report","summary_en":"Item 1.01: Entry into a Material Definitive Agreement;\nItem 3.02: Unregistered Sales of Equity Securities;\nItem 9.01: Financial Statements and Exhibits","summary_zh":"","notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":false,"hasAttachments":true,"id":"19616266","market":"us","labels":[],"media":"sec.gov","original_id":"AN121390025040810-NKGN","pdf_url":"","pub_time":1746676800000,"showTitleType":true,"size":0,"source":"sec_us","summary":"Form 8-K - Current report","symbol":"NKGN","title":"Form 8-K - Current report","titleType":"Major Issues Report","type":"usAnnouncement","url":"https://www.sec.gov/Archives/edgar/data/1845459/000121390025040810/0001213900-25-040810-index.htm","us_notice_code":"Form 8-K","us_title_en":"Item 1.01: Entry into a Material Definitive Agreement;\nItem 3.02: Unregistered Sales of Equity Securities;\nItem 7.01: Regulation FD Disclosure;\nItem 9.01: Financial Statements and Exhibits","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","attachments":[{"description":"COMMON STOCK PURCHASE WARRANT, DATED MAY 5, 2025, BY AND BETWEEN NKGEN BIOTECH,","seq":1,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1845459/000121390025040810/ea024094401ex4-1_nkgen.htm","primary":true,"translateUrl":"","linkName":"ea024094401ex4-1_nkgen.htm","type":"EX-4.1","id":"NTFILE4NSsAV9SLUvz7zf8","market":"us","size":133401},{"description":"CURRENT REPORT","seq":2,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1845459/000121390025040810/ea0240944-8k_nkgen.htm","primary":false,"translateUrl":"","linkName":"ea0240944-8k_nkgen.htm","type":"8-K","id":"NTFILEAtv2CQL2JSgA859m","market":"us","size":34229},{"description":"SECURITIES PURCHASE AGREEMENT, DATED MAY 5, 2025, BY AND BETWEEN NKGEN BIOTECH,","seq":3,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1845459/000121390025040810/ea024094401ex10-1_nkgen.htm","primary":false,"translateUrl":"","linkName":"ea024094401ex10-1_nkgen.htm","type":"EX-10.1","id":"NTFILE5qQR8hr3anLCjPQA","market":"us","size":171723},{"description":"PRESS RELEASE, DATED MAY 8, 2025","seq":4,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1845459/000121390025040810/ea024094401ex99-1_nkgen.htm","primary":false,"translateUrl":"","linkName":"ea024094401ex99-1_nkgen.htm","type":"EX-99.1","id":"NTFILEEggLyKaReBcr8pMG","market":"us","size":12629}],"type_name":"Transaction Related","type_name_en":"Transaction Related","titleTypeEn":"Major Issues Report","us_type":"交易披露","us_type_zh":"交易披露","earn_infos":[],"event_type":"important_notice","event_name":"Major Issues Report","pubTime":"2025-05-08 12:00","pubTimestamp":1746676800,"title_zh":"Form 8-K - Current report","summary_en":"Item 1.01: Entry into a Material Definitive Agreement;\nItem 3.02: Unregistered Sales of Equity Securities;\nItem 7.01: Regulation FD Disclosure;\nItem 9.01: Financial Statements and Exhibits","summary_zh":"","notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":false,"hasAttachments":true,"id":"19592458","market":"us","labels":[],"media":"sec.gov","original_id":"AN121390025038427-NKGN","pdf_url":"","pub_time":1746129908000,"showTitleType":true,"size":0,"source":"sec_us","summary":"Form 8-K - Current report","symbol":"NKGN","title":"Form 8-K - Current report","titleType":"Major Issues Report","type":"usAnnouncement","url":"https://www.sec.gov/Archives/edgar/data/1845459/0001213900-25-038427-index.html","us_notice_code":"Form 8-K","us_title_en":"Item 1.01: Entry into a Material Definitive Agreement;\nItem 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant;\nItem 9.01: Financial Statements and Exhibits","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","attachments":[{"description":"LETTER AGREEMENT, DATED APRIL 25, 2025, BY AND BETWEEN NKGEN BIOTECH, INC. AND K","seq":1,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1845459/000121390025038427/ea023978001ex10-1_nkgen.htm","primary":true,"translateUrl":"","linkName":"ea023978001ex10-1_nkgen.htm","type":"EX-10.1","id":"NTFILE4TBvW95T3nf3ZyF6","market":"us","size":21035},{"description":"CURRENT REPORT","seq":2,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1845459/000121390025038427/ea0239780-8k_nkgen.htm","primary":false,"translateUrl":"","linkName":"ea0239780-8k_nkgen.htm","type":"8-K","id":"NTFILErgYDEZntF2ZAgqYa","market":"us","size":32236}],"type_name":"Transaction Related","type_name_en":"Transaction Related","titleTypeEn":"Major Issues Report","us_type":"交易披露","us_type_zh":"交易披露","earn_infos":[],"event_type":"important_notice","event_name":"Major Issues Report","pubTime":"2025-05-02 04:05","pubTimestamp":1746129908,"title_zh":"Form 8-K - Current report","summary_en":"Item 1.01: Entry into a Material Definitive Agreement;\nItem 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant;\nItem 9.01: Financial Statements and Exhibits","summary_zh":"","notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":false,"hasAttachments":true,"id":"19454510","market":"us","labels":[],"media":"sec.gov","original_id":"AN121390025034184-NKGN","pdf_url":"","pub_time":1745352314000,"showTitleType":true,"size":0,"source":"sec_us","summary":"Form 8-K - Current report","symbol":"NKGN","title":"Form 8-K - Current report","titleType":"Major Issues Report","type":"usAnnouncement","url":"https://www.sec.gov/Archives/edgar/data/1845459/0001213900-25-034184-index.html","us_notice_code":"Form 8-K","us_title_en":"Item 1.01: Entry into a Material Definitive Agreement;\nItem 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant;\nItem 9.01: Financial Statements and Exhibits","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","attachments":[{"description":"LOAN AGREEMENT AMENDMENT, DATED APRIL 14, 2025, BY AND BETWEEN NKGEN BIOTECH, IN","seq":1,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1845459/000121390025034184/ea023906401ex10-1_nkgen.htm","primary":true,"translateUrl":"","linkName":"ea023906401ex10-1_nkgen.htm","type":"EX-10.1","id":"NTFILEA7sBy9Yb5c4sd6mY","market":"us","size":22966},{"description":"CURRENT REPORT","seq":2,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1845459/000121390025034184/ea0239064-8k_nkgen.htm","primary":false,"translateUrl":"","linkName":"ea0239064-8k_nkgen.htm","type":"8-K","id":"NTFILEBVtXnvTmh19a7k2A","market":"us","size":31115}],"type_name":"Transaction Related","type_name_en":"Transaction Related","titleTypeEn":"Major Issues Report","us_type":"交易披露","us_type_zh":"交易披露","earn_infos":[],"event_type":"important_notice","event_name":"Major Issues Report","pubTime":"2025-04-23 04:05","pubTimestamp":1745352314,"title_zh":"Form 8-K - Current report","summary_en":"Item 1.01: Entry into a Material Definitive Agreement;\nItem 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant;\nItem 9.01: Financial Statements and Exhibits","summary_zh":"","notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":false,"hasAttachments":true,"id":"19225638","market":"us","labels":[],"media":"sec.gov","original_id":"AN121390025022472-NKGN","pdf_url":"","pub_time":1741665600000,"showTitleType":true,"size":0,"source":"sec_us","summary":"Form 8-K - Current report","symbol":"NKGN","title":"Form 8-K - Current report","titleType":"Major Issues Report","type":"usAnnouncement","url":"https://www.sec.gov/Archives/edgar/data/1845459/000121390025022472/0001213900-25-022472-index.htm","us_notice_code":"Form 8-K","us_title_en":"Item 1.01: Entry into a Material Definitive Agreement;\nItem 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant;\nItem 3.02: Unregistered Sales of Equity Securities;\nItem 9.01: Financial Statements and Exhibits","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","attachments":[{"description":"COMMON STOCK PURCHASE WARRANT, DATED MARCH 10, 2025, ISSUED TO ALPINEBROOK CAPIT","seq":1,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1845459/000121390025022472/ea023389801ex4-1_nkgen.htm","primary":true,"translateUrl":"","linkName":"ea023389801ex4-1_nkgen.htm","type":"EX-4.1","id":"NTFILE4iMbLk1N9uyLKPzY","market":"us","size":141856},{"description":"CURRENT REPORT","seq":2,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1845459/000121390025022472/ea0233898-8k_nkgen.htm","primary":false,"translateUrl":"","linkName":"ea0233898-8k_nkgen.htm","type":"8-K","id":"NTFILE2JwRmjqakGZotL9t","market":"us","size":35941},{"description":"CONVERTIBLE LOAN AGREEMENT, DATED MARCH 10, 2025, BY AND AMONG NKGEN BIOTECH, IN","seq":3,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1845459/000121390025022472/ea023389801ex10-1_nkgen.htm","primary":false,"translateUrl":"","linkName":"ea023389801ex10-1_nkgen.htm","type":"EX-10.1","id":"NTFILE27C5pXE15wA7vLix","market":"us","size":187116},{"description":"CONVERTIBLE PROMISSORY NOTE, DATED MARCH 10, 2025, ISSUED TO ALPINEBROOK CAPITAL","seq":4,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1845459/000121390025022472/ea023389801ex10-2_nkgen.htm","primary":false,"translateUrl":"","linkName":"ea023389801ex10-2_nkgen.htm","type":"EX-10.2","id":"NTFILE3Dnsfnjid7Nrh5u3","market":"us","size":39642}],"type_name":"Transaction Related","type_name_en":"Transaction Related","titleTypeEn":"Major Issues Report","us_type":"交易披露","us_type_zh":"交易披露","earn_infos":[],"event_type":"important_notice","event_name":"Major Issues Report","pubTime":"2025-03-11 12:00","pubTimestamp":1741665600,"title_zh":"Form 8-K - Current report","summary_en":"Item 1.01: Entry into a Material Definitive Agreement;\nItem 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant;\nItem 3.02: Unregistered Sales of Equity Securities;\nItem 9.01: Financial Statements and Exhibits","summary_zh":"","notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":false,"hasAttachments":true,"id":"19196311","market":"us","labels":[],"media":"sec.gov","original_id":"AN162828025009614-NKGN","pdf_url":"","pub_time":1741064400000,"showTitleType":true,"size":0,"source":"sec_us","summary":"Form 10-Q - Quarterly report [Sections 13 or 15(d)]","symbol":"NKGN","title":"Form 10-Q - Quarterly report [Sections 13 or 15(d)]","titleType":"Quarterly Report","type":"usFinancials","url":"https://www.sec.gov/Archives/edgar/data/1845459/000162828025009614/0001628280-25-009614-index.htm","us_notice_code":"Form 10-Q","us_title_en":"Form 10-Q - Quarterly report [Sections 13 or 15(d)]","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","attachments":[{"description":"10-Q","seq":1,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1845459/000162828025009614/nkgn-20240930.htm","primary":true,"translateUrl":"","linkName":"nkgn-20240930.htm","type":"10-Q","id":"NTFILE8jYjm15wuVsNhvqq","market":"us","size":2292104},{"description":"EX-31.1","seq":2,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1845459/000162828025009614/nkgenbiotechinc-ex311q32024.htm","primary":false,"translateUrl":"","linkName":"nkgenbiotechinc-ex311q32024.htm","type":"EX-31.1","id":"NTFILE4mhHp4xS4BXgJzUu","market":"us","size":8369},{"description":"EX-31.2","seq":3,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1845459/000162828025009614/nkgenbiotechinc-ex312q32024.htm","primary":false,"translateUrl":"","linkName":"nkgenbiotechinc-ex312q32024.htm","type":"EX-31.2","id":"NTFILEAkYQT7RFzw5KjtX3","market":"us","size":8403},{"description":"EX-32.1","seq":4,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1845459/000162828025009614/nkgenbiotechinc-ex321q32024.htm","primary":false,"translateUrl":"","linkName":"nkgenbiotechinc-ex321q32024.htm","type":"EX-32.1","id":"NTFILECCcHooHy1fWsZuwu","market":"us","size":7100}],"type_name":"Financial Report","type_name_en":"Financial Report","titleTypeEn":"Quarterly Report","us_type":"财务报告","us_type_zh":"财务报告","earn_infos":[],"event_type":"important_notice","event_name":"Quarterly Report","pubTime":"2025-03-04 13:00","pubTimestamp":1741064400,"title_zh":"Form 10-Q - Quarterly report [Sections 13 or 15(d","summary_en":"","summary_zh":"","notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":false,"hasAttachments":true,"id":"19167619","market":"us","labels":[],"media":"sec.gov","original_id":"AN121390025017098-NKGN","pdf_url":"","pub_time":1740519009000,"showTitleType":true,"size":0,"source":"sec_us","summary":"Form 8-K - Current report","symbol":"NKGN","title":"Form 8-K - Current report","titleType":"Major Issues Report","type":"usAnnouncement","url":"https://www.sec.gov/Archives/edgar/data/1845459/0001213900-25-017098-index.html","us_notice_code":"Form 8-K","us_title_en":"Item 5.07: Submission of Matters to a Vote of Security Holders;\nItem 8.01: Other Events","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","attachments":[{"description":"CURRENT REPORT","seq":1,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1845459/000121390025017098/ea0232141-8k_nkgen.htm","primary":true,"translateUrl":"","linkName":"ea0232141-8k_nkgen.htm","type":"8-K","id":"NTFILEHrXaKoAgU15hVfyJ","market":"us","size":33769}],"type_name":"Transaction Related","type_name_en":"Transaction Related","titleTypeEn":"Major Issues Report","us_type":"交易披露","us_type_zh":"交易披露","earn_infos":[],"event_type":"important_notice","event_name":"Major Issues Report","pubTime":"2025-02-26 05:30","pubTimestamp":1740519009,"title_zh":"Form 8-K - Current report","summary_en":"Item 5.07: Submission of Matters to a Vote of Security Holders;\nItem 8.01: Other Events","summary_zh":"","notice_type":"","filling_tag":"","gpt_icon":0}],"pageSize":20,"totalPage":6,"pageCount":1,"totalSize":113,"code":"91000000","status":"200"}]}}